Abstract:Background & Aims In about 20% of children with cholestasis and normal or low serum gamma-glutamyltransferase (GGT) activity, no aetiology is identified. We sought new genes implicated in paediatric hepatobiliary disease. Methods We conducted whole-exome sequencing in 69 children evaluated at our centre from 2011 to 2018 who had low-GGT cholestasis and in whom homozygous/compound heterozygous predictedly pathogenic variants (PPVs) in ATP8B1, ABCB11, NR1H4, MYO5B or TJP2 were not found. Clinical records and findings on light microscopy and transmission electron microscopy of liver biopsy materials were reviewed. Results In seven patients from seven unrelated families, biallelic PPVs (10 in total) were found in USP53, recently associated with intrahepatic cholestasis. Seven variants were classified as pathogenic: one canonical splicing, c.569 + 2T > C, and six nonsense or frameshifting: c.169C > T (p.Arg57Ter), c.581delA (p.Arg195GlufsTer38), c.831_832insAG (p.Val279GlufsTer16), c.1012C > T (p.Arg338Ter), c.1426C > T (p.Arg476Ter) and c.1558C > T (p.Arg520Ter). Three were likely pathogenic: c.297G > T (p.Arg99Ser), c.395A > G (p.His132Arg) and c.878G > T (p.Gly293Val). In all patients, jaundice began at age <7 months. Cholestasis was transient, with documented resolution of hyperbilirubinaemia in all (oldest patient now aged 5 years) except one, who was lost to follow-up. Light microscopy identified intralobular cholestasis, giant-cell change of hepatocytes and perisinusoidal-perihepatocytic and portal-tract fibrosis. Ultrastructural study revealed elongated hepatocyte-hepatocyte tight junctions. One patient was deaf. Conclusion USP53 interacts with the tight junction constituent TJP2. TJP2 mutation can cause low-GGT intrahepatic cholestasis, with elongated hepatocyte-hepatocyte tight junctions, as well as deafness. Our findings extend a preliminary report of USP53 disease and indicate that USP53 mutation may generate a partial phenocopy of TJP2 disease.

Unequal effects of MYO5B mutations in liver and intestine determine the clinical presentation of low-GGT cholestasis.

Unequal Effects Of Myosin 5b Mutations In Liver And Intestine Determine The Clinical Presentation Of Low-Gamma-Glutamyltransferase Cholestasis

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

A Molecular Mechanism Underlying Genotype‐Specific Intrahepatic Cholestasis Resulting from MYO5B Mutations

Association of novel <i>TMEM67</i> variants with mild phenotypes of high gamma-glutamyl transpeptidase cholestasis and congenital hepatic fibrosis

Biallelic Loss-of-function ZFYVE19 Mutations Are Associated with Congenital Hepatic Fibrosis, Sclerosing Cholangiopathy and High-Ggt Cholestasis

MYO5B ‐associated diseases: Novel liver‐related variants and genotype‐phenotype correlation

<i>MYO5B</i>-associated diseases: Novel liver-related variants and genotype-phenotype correlation

Case Report: MYO5B Homozygous Variant c.2090+3A>T Causes Intron Retention Related to Chronic Cholestasis and Diarrhea

Splicing Analysis of MYO5B Noncanonical Variants in Patients with Low Gamma-Glutamyltransferase Cholestasis

[Clinical Features and MYO5B Mutations of a Family Affected by Microvillus Inclusion Disease].

Low-GGT Intrahepatic Cholestasis Associated with Biallelic USP53 Variants: Clinical, Histological and Ultrastructural Characterization

Hepatic Tmem30a Deficiency Causes Intrahepatic Cholestasis by Impairing Expression and Localization of Bile Salt Transporters.

Novel Missense Mutation in VPS33B is Associated with Isolated Low Gamma-Glutamyltransferase Cholestasis: Attenuated, Incomplete Phenotype of Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome.

MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report

Altered cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation

Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation

434 CHARACTERIZATION OF ATP8B1 GENE MUTATIONS AND A HOT LINKED MUTATION FOUND IN CHINESE CHILDREN WITH PROGRESSIVE INTRAHEPATIC CHOLESTASIS AND LOW GGT

Two Cases of Microvillus Inclusion Disease Caused by MYO5B Deficiency with Prenatal Abnormalities.

Molecular Findings in Children with Inherited Intrahepatic Cholestasis

[Phenotypic and genetic analysis of a family affected with microvillus inclusion disease].